DE3881895D1 - Verfahren zur reinigung von vitamin-k-abhaengigen blutgerinnungsfaktoren. - Google Patents

Verfahren zur reinigung von vitamin-k-abhaengigen blutgerinnungsfaktoren.

Info

Publication number
DE3881895D1
DE3881895D1 DE8989901619T DE3881895T DE3881895D1 DE 3881895 D1 DE3881895 D1 DE 3881895D1 DE 8989901619 T DE8989901619 T DE 8989901619T DE 3881895 T DE3881895 T DE 3881895T DE 3881895 D1 DE3881895 D1 DE 3881895D1
Authority
DE
Germany
Prior art keywords
factors
cointenance
dependent blood
purifying vitamin
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989901619T
Other languages
English (en)
Other versions
DE3881895T2 (de
Inventor
Peter Feldman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central Blood Laboratories Authority
Original Assignee
Central Blood Laboratories Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Blood Laboratories Authority filed Critical Central Blood Laboratories Authority
Publication of DE3881895D1 publication Critical patent/DE3881895D1/de
Application granted granted Critical
Publication of DE3881895T2 publication Critical patent/DE3881895T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Cooling, Air Intake And Gas Exhaust, And Fuel Tank Arrangements In Propulsion Units (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
DE89901619T 1987-12-22 1988-12-22 Verfahren zur Reinigung von Vitamin-K-abhängigen Blutgerinnungsfaktoren. Expired - Fee Related DE3881895T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878729822A GB8729822D0 (en) 1987-12-22 1987-12-22 Chemical process

Publications (2)

Publication Number Publication Date
DE3881895D1 true DE3881895D1 (de) 1993-07-22
DE3881895T2 DE3881895T2 (de) 1993-12-02

Family

ID=10628844

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89901619T Expired - Fee Related DE3881895T2 (de) 1987-12-22 1988-12-22 Verfahren zur Reinigung von Vitamin-K-abhängigen Blutgerinnungsfaktoren.

Country Status (9)

Country Link
EP (1) EP0391974B1 (de)
JP (1) JPH0664B2 (de)
AT (1) ATE90567T1 (de)
AU (1) AU627446B2 (de)
DE (1) DE3881895T2 (de)
DK (1) DK175514B1 (de)
GB (1) GB8729822D0 (de)
NO (1) NO178882C (de)
WO (1) WO1989005650A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4430204A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Arzneimittel, welches als Gegenmittel für Blut-Antikoagulanzien geeignet ist und seine Verwendung
US5589571A (en) * 1994-10-28 1996-12-31 Cor Therapeutics, Inc. Process for production of inhibited forms of activated blood factors
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
AT409334B (de) * 1997-09-19 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
SE0203551D0 (sv) * 2002-12-02 2002-12-02 Biovitrum Ab Prothrombin purification
US20060068454A1 (en) * 2004-09-27 2006-03-30 Sysmex Corporation Method of inactivating blood coagulation factor and blood coagulation factor-inactivated sample
GB0710321D0 (en) * 2007-05-30 2007-07-11 Nhs Blood & Transplant Method
US9956272B2 (en) 2007-05-30 2018-05-01 Bio Products Laboratory Limited Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
CN104328036B (zh) * 2014-10-28 2016-08-24 成都英德生物医药装备技术有限公司 一种人凝血酶原复合物吸附分离装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2303466C2 (de) * 1973-01-25 1975-03-20 Stanislaus Dipl.-Ing. 7340 Geislingen Malik Verfahren zur Herstellung eines Wabenträgers
JPS5263835A (en) * 1975-11-21 1977-05-26 Hokusan Kk Method of fabricating light shaped steel material
US4473553A (en) * 1983-12-02 1984-09-25 Miles Laboratories, Inc. Process for producing a lipoprotein-poor concentrate of coagulation factors VII and VIIa
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins

Also Published As

Publication number Publication date
AU627446B2 (en) 1992-08-27
NO178882B (no) 1996-03-18
NO902757L (no) 1990-06-21
NO178882C (no) 1996-06-26
EP0391974A1 (de) 1990-10-17
WO1989005650A2 (en) 1989-06-29
GB8729822D0 (en) 1988-02-03
DK153490A (da) 1990-06-22
DK153490D0 (da) 1990-06-22
ATE90567T1 (de) 1993-07-15
EP0391974B1 (de) 1993-06-16
AU3032989A (en) 1989-07-19
JPH03501085A (ja) 1991-03-14
JPH0664B2 (ja) 1994-01-05
DE3881895T2 (de) 1993-12-02
WO1989005650A3 (en) 1989-07-27
DK175514B1 (da) 2004-11-15
NO902757D0 (no) 1990-06-21

Similar Documents

Publication Publication Date Title
DE3881895D1 (de) Verfahren zur reinigung von vitamin-k-abhaengigen blutgerinnungsfaktoren.
ATE200293T1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
ES2168387T3 (es) Procedimiento de fraccionamiento de soluciones que contienen sacarosa.
ATE216625T1 (de) Methode zur chromatographischen trennung von kationen aus wässrigen proben
DK0425066T3 (da) Krystallinsk 2-O-alpha-D-glucopyranosyl-L-ascorbinsyre og fremstilling heraf og anvendelser herfor
DK0491757T4 (da) Fremgangsmåde til inaktivering af vira i blod og blodprodukter
MX168497B (es) Ultrafiltracion de flujo tangencial por afinidad
DK84288D0 (da) Fusionsproteiner og oprensning deraf
EP0244834A3 (en) Process for producing a factor v concentrate
ATE114172T1 (de) Reinigungsverfahren für antikörper.
DE3869301D1 (de) Methode zum reinigen von giftige komponenten enthaltendem gas.
ATE184018T1 (de) Verfahren zur isolation von hoch angereicherten faktoren ix, x und ii vom prothrombin komplex oder menschlichem plasma
DE3587298D1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
DE59006656D1 (de) Verfahren zur Trennung und Rückgewinnung von Komponenten von Gemischen mittels Pervaporation.
EP0450099A4 (en) Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor
HU9200225D0 (en) Complex process containing anti-coagulant ix-factor
ATE154033T1 (de) Verfahren zur reinigung von proteinen
ATE98649T1 (de) Reinigung von lfa-3.
ATE22705T1 (de) Verfahren zur herstellung von staehlen mit hoher zerspanbarkeit (automatenstahl).
DE69434001D1 (de) Reinigung von vitamin-k abhaengigen proteinen durch membrane chromatographie
DE69433875D1 (de) Verfahren zur präparation von humanem aktiviertem protein c
GR3015397T3 (en) Separation of anti-metal chelate antibodies.
DE3577809D1 (de) Verfahren zur trennung von wasserstoffisotopen.
ATE96910T1 (de) Verfahren zum stabilisieren von prostatspezifisch-antigen in natuerlichen matrizen.
DK0846166T3 (da) Fremgangsmåde til thrombinfremstilling

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8339 Ceased/non-payment of the annual fee